相关实验视频
Updated: May 4, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
30.6K
赫西丁对比Povidone-Iodine用于静脉内注射的消毒:一个系统的审查和元分析
Andrew Mihalache1, Brendan K Tao2, Ryan S Huang1
1From the Temerty Faculty of Medicine (A.M. and R.S.H.), University of Toronto, Toronto, Ontario, Canada.
American journal of ophthalmology
|March 28, 2025
概括
赫西丁 (CHX) 和波维- (PI) 在预防注射后内炎 (PIE) 中表现出类似的疗效. 与PI相比,CHX提供了更好的安全性概况和减少疼痛,感染Staphylococcus epidermidis的几率更低.
科学领域:
- 眼科医生 眼科 眼科
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 波维- (PI) 是用于注射后内炎 (PIE) 预防的标准消毒剂.
- 赫西丁 (CHX) 是一种替代性消毒剂,有可能提高患者的耐受性.
研究的目的:
- 系统地审查和比较CHX与PI在PIE预防中的疗效和安全性.
- 分析包括PIE发病率,视力敏度,患者耐受性和微生物培养在内的结果.
主要方法:
- 对比CHX和PI的研究进行系统综述和随机效应元分析.
- 从2000年1月到2024年7月,在MEDLINE,Embase和Cochrane图书馆进行文献搜索.
- 主要结局:比较PIE发病率;次要结局:最佳校正视敏度 (BCVA),患者不耐受,疼痛和微生物培养.
主要成果:
- 在CHX和PI之间,假定,培养阳性或培养负性的PIE率没有显著差异.
- 在CHX组中,出现Staphylococcus epidermidis endophthalmitis的几率显著降低 (OR = 0.15,P = .004).
- 与PI相比,CHX显示患者耐受性得到改善,疼痛减少,角膜上皮质病变减少.
结论:
- CHX和PI在预防PIE方面表现出相似的疗效,在内眼炎病例中视觉预后类似.
- 与PI相比,CHX提供了优越的安全性和疼痛概况.
- 在内炎病例中,CHX与S. epidermidis感染的风险降低有关.
相关概念视频
Hand hygiene
5.2K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
5.2K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
259
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
259

